UK MHRA outlines data integrity expectations for pharma industry

The UK's Medicines and Healthcare products Regulatory Agency has issued its first ever guidance on data integrity, which is a fundamental component of a pharmaceutical quality system and ensures that medicines are of the required quality1.

The UK's Medicines and Healthcare products Regulatory Agency has issued its first ever guidance on data integrity, which is a fundamental component of a pharmaceutical quality system and ensures that medicines are of the required quality1.

Of late, data integrity issues have drawn the attention of drug regulatory authorities worldwide and several companies, especially from India,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet